Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lck (lymphocyte-specific protein tyrosine kinase) is a non-receptor tyrosine-protein kinase and a member of the Src family of protein tyrosine kinases. It is essential for T-cell development, selection, maturation in the thymus, and function of mature T-cells. It plays a central role in initiating signaling from the T-cell antigen receptor (TCR). Altered expression or activity of Lck has been implicated in various diseases including immunodeficiency, cancer and autoimmune/inflammatory conditions. It is being explored as a therapeutic target for both oncology and autoimmune/inflammatory conditions.
Src family kinase inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proto-oncogene tyrosine-protein kinase Lck (LCK).